JPWO2023277168A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023277168A5
JPWO2023277168A5 JP2023532082A JP2023532082A JPWO2023277168A5 JP WO2023277168 A5 JPWO2023277168 A5 JP WO2023277168A5 JP 2023532082 A JP2023532082 A JP 2023532082A JP 2023532082 A JP2023532082 A JP 2023532082A JP WO2023277168 A5 JPWO2023277168 A5 JP WO2023277168A5
Authority
JP
Japan
Prior art keywords
polynucleotide
nucleotides
modified
sugar
nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023532082A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023277168A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/026411 external-priority patent/WO2023277168A1/ja
Publication of JPWO2023277168A1 publication Critical patent/JPWO2023277168A1/ja
Publication of JPWO2023277168A5 publication Critical patent/JPWO2023277168A5/ja
Pending legal-status Critical Current

Links

JP2023532082A 2021-06-30 2022-06-30 Pending JPWO2023277168A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021109239 2021-06-30
JP2021169846 2021-10-15
PCT/JP2022/026411 WO2023277168A1 (ja) 2021-06-30 2022-06-30 ポリヌクレオチド及び医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2023277168A1 JPWO2023277168A1 (cg-RX-API-DMAC7.html) 2023-01-05
JPWO2023277168A5 true JPWO2023277168A5 (cg-RX-API-DMAC7.html) 2025-07-02

Family

ID=84692765

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023532082A Pending JPWO2023277168A1 (cg-RX-API-DMAC7.html) 2021-06-30 2022-06-30

Country Status (7)

Country Link
US (1) US20240325426A1 (cg-RX-API-DMAC7.html)
EP (1) EP4365288A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023277168A1 (cg-RX-API-DMAC7.html)
KR (1) KR20240026181A (cg-RX-API-DMAC7.html)
AU (1) AU2022302611A1 (cg-RX-API-DMAC7.html)
CA (1) CA3225964A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023277168A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024185697A1 (ja) * 2023-03-03 2024-09-12 国立大学法人東海国立大学機構 ポリヌクレオチド連結産物の製造方法
WO2025111430A1 (en) * 2023-11-21 2025-05-30 Prime Medicine, Inc. CHEMICAL MODIFICATIONS IN mRNA POLY(A) TAIL
WO2026010855A1 (en) * 2024-07-02 2026-01-08 Trilink Biotechnologies, Llc Modified rna for increasing protein expression

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01114346A (ja) 1987-10-26 1989-05-08 Seiko Electronic Components Ltd 冷却ファン付モータ
EP1021549A2 (en) * 1997-09-19 2000-07-26 Sequitur, Inc. SENSE mRNA THERAPY
WO2009135212A2 (en) * 2008-05-02 2009-11-05 Epicentre Technologies Corporation Selective 5' ligation tagging of rna
US10086043B2 (en) * 2011-04-03 2018-10-02 The General Hospital Corporation Efficient protein expression in vivo using modified RNA (MOD-RNA)
JP5678022B2 (ja) 2012-10-31 2015-02-25 京セラドキュメントソリューションズ株式会社 画像形成装置及び画像形成プログラム
EP3434774A1 (en) * 2013-01-17 2019-01-30 ModernaTX, Inc. Signal-sensor polynucleotides for the alteration of cellular phenotypes
US20170202979A1 (en) * 2014-07-17 2017-07-20 Modernatx, Inc. Terminal modifications of polynucleotides
JP6275576B2 (ja) 2014-07-24 2018-02-07 ヤンマー株式会社 作業車輌
EP3177732A4 (en) 2014-08-08 2018-04-25 ModernaTX, Inc. Compositions and methods for the treatment of ophthalmic diseases and conditions
WO2016100812A1 (en) * 2014-12-19 2016-06-23 Moderna Therapeutics, Inc. Terminal modifications of polynucleotides
SMT202500412T1 (it) 2016-01-11 2025-11-10 Innate Tumor Immunity Inc Dinucleotidi ciclici per il trattamento di condizioni associate all’attività di sting quali il cancro
KR20220122701A (ko) * 2019-12-26 2022-09-02 내셔널 유니버시티 코포레이션 토카이 내셔널 하이어 에듀케이션 앤드 리서치 시스템 폴리뉴클레오티드 및 의약 조성물

Similar Documents

Publication Publication Date Title
RU2017114156A (ru) N-ацетилгалактозаминовые (galnac) фосфорамитиды, их конъюгаты с нуклеиновыми кислотами и их применение
JP6284977B2 (ja) 2’−o−修飾rna
KR20240028502A (ko) 핵산 리간드 및 이의 접합체, 및 이를 위한 제조 방법 및 이의 용도
JP2023113843A5 (cg-RX-API-DMAC7.html)
JP2023536320A5 (cg-RX-API-DMAC7.html)
JP2022519019A5 (cg-RX-API-DMAC7.html)
JP2009524696A5 (cg-RX-API-DMAC7.html)
JP2019522972A5 (cg-RX-API-DMAC7.html)
JP7736489B2 (ja) オリゴヌクレオチド組成物及びその作製方法
JP2016523087A5 (cg-RX-API-DMAC7.html)
JP2015518714A5 (cg-RX-API-DMAC7.html)
WO2019002237A1 (en) METHOD OF MULTIPLE COUPLING AND OXIDATION
JP2021505129A5 (cg-RX-API-DMAC7.html)
RU2020115761A (ru) МОЛЕКУЛЫ НУКЛЕИНОВЫХ КИСЛОТ ДЛЯ УМЕНЬШЕНИЯ УРОВНЯ мРНК PAPD5 ИЛИ PAPD7 ДЛЯ ЛЕЧЕНИЯ ИНФЕКЦИОННОГО ГЕПАТИТА В
JP2019213567A (ja) ヘアピン型一本鎖rna分子の製造方法
WO2018177825A1 (en) Orthogonal protecting groups for the preparation of stereodefined phosphorothioate oligonucleotides
AU2023231320A1 (en) Application of tetracyclic compound in treatment of tumors
CN119528986B (zh) 一种核苷类似物及其在降低寡核苷酸药物脱靶活性中的应用
JPWO2021070494A5 (cg-RX-API-DMAC7.html)
US20230220386A1 (en) Sirna conjugate, double-stranded sirna conjugate, salt thereof and application thereof
JPWO2023089976A5 (cg-RX-API-DMAC7.html)
JP2000512630A (ja) 2’―置換ヌクレオシドおよびオリゴヌクレオチド誘導体
US20130066061A1 (en) Purification of oligonucleotides
JP2023528966A (ja) 二本鎖siRNA類似体のコンジュゲート
WO2023140040A1 (ja) アミダイトモノマー